We are live on
!
Find out more
XI
XXEC Inc Portfolio holdings
AUM
$571M
1-Year Est. Return
1.42%
This Fund
S&P 500
This Quarter
Est. Return
+15.51%
1 Year Est. Return
-1.42%
3 Year Est. Return
+24.23%
5 Year Est. Return
+35.66%
10 Year Est. Return
–
AUM
$125M
AUM Growth
+$8.54M
(+7.4%)
Cap. Flow
-$5.38M
Cap. Flow
% of AUM
-4.31%
Top 10 Holdings %
Top 10 Hldgs %
61.54%
Holding
29
New
4
Increased
11
Reduced
6
Closed
3
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Idexx Laboratories
IDXX
|
+$2.79M |
| 2 |
Deere & Co
DE
|
+$2.09M |
| 3 |
Badger Meter
BMI
|
+$2.04M |
| 4 |
Xylem
XYL
|
+$965K |
| 5 |
Nike
NKE
|
+$763K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Generac Holdings
GNRC
|
+$6.81M |
| 2 |
CTLT
CATALENT, INC.
CTLT
|
+$5.17M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$1.91M |
| 4 |
Zoetis
ZTS
|
+$125K |
| 5 |
Fair Isaac
FICO
|
+$82.1K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 37.39% |
| 2 | Healthcare | 27.32% |
| 3 | Financials | 23.24% |
| 4 | Industrials | 11.34% |
| 5 | Consumer Discretionary | 0.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
26
Nike
NKE
$62.7B
| $887K | 0.71% |
+7,580
| New | +$763K |
|
|
27
Generac Holdings
GNRC
$11.3B
| – | – |
-38,248
| Closed | -$6.81M |
|
|
28
Alphabet (Google) Class A
GOOGL
$4.08T
| – | – |
-20,000
| Closed | -$1.91M |
|
|
CTLT
29
DELISTED
CATALENT, INC.
CTLT
| – | – |
-71,416
| Closed | -$5.17M |
|
Similar funds
RI
TWA
BSG
MW
MAM
FRM
NA
EHI
XXEC Inc's Q4 2022 Portfolio in Review
As of Q4 2022, XXEC Inc held 29 positions worth $125M, up 7.4% from $116M the previous quarter. Its ten largest holdings account for 62% of the portfolio.
XXEC Inc withdrew a net $5.38M in Q4 2022, closing 3 positions and reducing 6 holdings. Its most notable exit was Generac Holdings, an estimated $6.81M position sold in full.
By sector, the portfolio is most concentrated in Technology at 37% of assets, up from 34% a quarter earlier, followed by Healthcare and Financials.
Against the trend, XXEC Inc opened a new position in Idexx Laboratories worth $2.94M.
- XXEC Inc's largest Q4 2022 buy was Idexx Laboratories: 7,200 shares worth $2.94M.
- XXEC Inc added most to Xylem in Q4 2022, an estimated $965K increase.
- XXEC Inc's biggest Q4 2022 reduction was Zoetis, cutting an estimated $125K.
- XXEC Inc fully exited Generac Holdings in Q4 2022, selling an estimated $6.81M.
- XXEC Inc's ten largest holdings make up 62% of its $125M portfolio in Q4 2022.
- XXEC Inc opened 4 new positions and closed 3 in Q4 2022.
- XXEC Inc's portfolio value rose 7.4% quarter-over-quarter to $125M.
Based on XXEC Inc's 13F filing for Q4 2022, filed 2 Feb 2023.